Omega Fund Management, LLC Long-Term Concentrated

Location: Boston, MA

CIK: 0001637359 · Show all filings

Period: Q2 2023 (← Previous) (Next →)

Filing Date: Aug 14, 2023

Total Value: $178M (100.0% shares, 0.0% debt)

Holdings (12)

REPL Replimune Group 39.0%

Value $69.69M Shares 3,001,319 Est. Cost $17.40 Unrealized +12.3%

NUVB Nuvation Bio 15.2%

Value $27.13M Shares 15,072,340 Est. Cost $11.18 Unrealized -84.8%

— Alpine Immune Sciences 11.7%

Value $20.86M Shares 2,029,580 Est. Cost $9.48 Unrealized —

— Morphic Holding 10.0%

Value $17.76M Shares 309,846 Est. Cost $19.82 Unrealized —

— Ikena Oncology 8.3%

Value $14.75M Shares 2,249,123 Est. Cost $28.25 Unrealized —

— Theseus Pharmaceuticals 3.7%

Value $6.638M Shares 711,479 Est. Cost $12.68 Unrealized —

— Kronos Bio 3.7%

Value $6.567M Shares 3,818,283 Est. Cost $29.87 Unrealized —

SANA Sana Biotechnology, Inc. 2.8%

Value $5.029M Shares 843,750 Est. Cost $32.56 Unrealized -82.3%

— Spruce Biosciences 2.6%

Value $4.646M Shares 2,161,022 Est. Cost $24.31 Unrealized —

IMUX Immunic Inc 2.5%

Value $4.488M Shares 1,788,160 Est. Cost $13.89 Unrealized -87.9%

SYRS Syros Pharmaceuticals 0.4%

Value $792K Shares 251,270 Est. Cost $8.12 Unrealized -60.4%

— Senti Biosciences, Inc. 0.1%

Value $123K Shares 195,792 Est. Cost $1.97 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
REPL	Replimune Group	3,001,319	$69.69M	39.0%	$17.40	+12.3%	Common Stock	76029N106
NUVB	Nuvation Bio	15,072,340	$27.13M	15.2%	$11.18	-84.8%	Common Stock Class A	67080N101
—	Alpine Immune Sciences	2,029,580	$20.86M	11.7%	$9.48	—	Common Stock	02083G100
—	Morphic Holding	309,846	$17.76M	10.0%	$19.82	—	Common Stock	61775R105
—	Ikena Oncology	2,249,123	$14.75M	8.3%	$28.25	—	Common Stock	45175G108
—	Theseus Pharmaceuticals	711,479	$6.638M	3.7%	$12.68	—	Common Stock	88369M101
—	Kronos Bio	3,818,283	$6.567M	3.7%	$29.87	—	Common Stock	50107A104
SANA	Sana Biotechnology, Inc.	843,750	$5.029M	2.8%	$32.56	-82.3%	Common Stock	799566104
—	Spruce Biosciences	2,161,022	$4.646M	2.6%	$24.31	—	Common Stock	85209E109
IMUX	Immunic Inc	1,788,160	$4.488M	2.5%	$13.89	-87.9%	Common Stock	4525EP101
SYRS	Syros Pharmaceuticals	251,270	$792K	0.4%	$8.12	-60.4%	Common Stock	87184Q206
—	Senti Biosciences, Inc.	195,792	$123K	0.1%	$1.97	—	Common Stock	81726A100